Send Message
Home News

company news about COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide

China Hangzhou AllTest Biotech CO.,LTD certification
Customer Reviews
We recently started selling your HCG tests via our Australian partner and have been very impressed with the quality and consistency of the tests. They seem to be superior to our current manufacturer and we also know that you are far more reliable in terms of production times and communication.

—— One customer from Europe

We would like to explore the possibility of switching our HCG tests over to you. We have been reluctant in the past to move everything over to you as it makes us very reliant on you. However, we have always found you to be by far the most reliable of all our Chinese manufacturers and so we feel comfortable strengthening our partnership further

—— One customer from Europe

I like the products and service provided by AllTest. They really take our interest into consideration.

—— Mr John Smith England

My oldest daughter actually has Lyme disease. She spent almost 1 year in a wheelchair because of Lyme. She is doing very well now. I used 2 of the samples. 1 to test my Lyme diagnosed daughter and 1 to test my daughter who does not have Lyme. Your tests worked well. My daughter with Lyme tested positive and the one who does not tested negative.

—— Ms Sheila

Whenever I have the requests,AllTest always give me the satisfied reply at the first time.

—— Mrs Julie Tschetter Belgium

As the old customer of AllTest since 2009, we should thank the great work have been done by AllTest to support us gain more market share and profit

—— Mr Robin Seifert Germany

I'm Online Chat Now
Company News
COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide
Latest company news about COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide

COVID-19 pandemic triggers 25% increase in prevalence of anxiety and depression worldwide


According to the World Health Organization (WHO), the prevalence of anxiety and depression increased significantly by 25% globally during the first year of the COVID-19 epidemic. The WHO highlights the groups most affected and summarizes the impact of the new crown epidemic on the availability of mental health services and how this has changed over the course of the epidemic.


One major explanation for the increase is the unprecedented stress caused by the social isolation resulting from the COVID-19. In addition, loneliness, fear of infection, pain and death for one's friends or families, and financial worries have been identified as stressors that lead to anxiety and depression. Among health workers, exhaustion is a major trigger for suicidal thoughts.


  • Young People and Women Worst Hit


The COVID-19 epidemic has affected the mental health of young people, who are at very high risk of adopting suicidal and self-harming behaviors. In addition, the survey reports that women are more severely affected than men and that people with underlying medical conditions such as asthma, cancer and heart disease are more likely to experience symptoms of mental disorders.


  • Gaps in Care


While rates of mental health problems have increased, mental health services have been severely disrupted, leaving a huge legacy of unattended care for those most in need. For much of the COVID-19 epidemic, people have experienced increased mental stress and a lack of security. Many people have taken self-protective measures, such as purchasing COVID-19 Self-Testing Kits to ensure their safety. This greatly enhances the sense of security as well as calms the mental stress. Despite this, many countries have also shown that some life-saving mental health services have suffered significant disruptions from the new crown epidemic.


  • WHO and country action


WHO Member States have recognized the impact of COVID-19 on mental health and are taking action. 90% of the world's countries are working to provide mental health and psychosocial support to COVID-19 patients and health care workers







Pub Time : 2022-03-14 14:09:08 >> News list
Contact Details
Hangzhou AllTest Biotech CO.,LTD

Contact Person: Mrs. Selina

Tel: 86-13989889852

Send your inquiry directly to us (0 / 3000)